1. Home
  2. VOR

as of 12-05-2025 3:40pm EST

$8.13
$0.20
-2.40%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Chart Type:
Time Range:
Founded: 2015 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 207.1M IPO Year: 2021
Target Price: $70.43 AVG Volume (30 days): 1.1M
Analyst Decision: Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -431.80 EPS Growth: N/A
52 Week Low/High: $2.62 - $65.80 Next Earning Date: 11-13-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered VOR Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 72.11%
72.11%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Vor Biopharma Inc. (VOR)

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Sell
VOR Oct 30, 2025

Avg Cost/Share

$25.12

Shares

24,579

Total Value

$617,424.48

Owned After

779,652

SEC Form 4

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Sell
VOR Oct 29, 2025

Avg Cost/Share

$25.22

Shares

251,518

Total Value

$6,343,283.96

Owned After

779,652

SEC Form 4

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Sell
VOR Oct 28, 2025

Avg Cost/Share

$27.64

Shares

124,311

Total Value

$3,408,229.74

Owned After

779,652

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Sell
VOR Oct 27, 2025

Avg Cost/Share

$28.12

Shares

90,941

Total Value

$2,557,260.92

Owned After

779,652

SEC Form 4

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Sell
VOR Oct 24, 2025

Avg Cost/Share

$28.01

Shares

53,345

Total Value

$1,494,193.45

Owned After

779,652

SEC Form 4

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Sell
VOR Oct 23, 2025

Avg Cost/Share

$28.01

Shares

76,880

Total Value

$2,153,408.80

Owned After

779,652

SEC Form 4

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Sell
VOR Oct 21, 2025

Avg Cost/Share

$28.11

Shares

25,027

Total Value

$703,508.97

Owned After

779,652

SEC Form 4

VOR Oct 21, 2025

Avg Cost/Share

$30.08

Shares

200

Total Value

$6,015.00

Owned After

1,166,909

SEC Form 4

RA CAPITAL MANAGEMENT, L.P.

Director, 10% Owner

Sell
VOR Oct 20, 2025

Avg Cost/Share

$29.88

Shares

92,023

Total Value

$2,730,483.09

Owned After

779,652

SEC Form 4

VOR Oct 20, 2025

Avg Cost/Share

$30.05

Shares

11,616

Total Value

$349,101.46

Owned After

1,166,909

SEC Form 4

Latest Vor Biopharma Inc. News

VOR Breaking Stock News: Dive into VOR Ticker-Specific Updates for Smart Investing

All VOR News

Share on Social Networks: